Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
出版年份 2021 全文链接
标题
Management of individuals with germline variants in PALB2: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
作者
关键词
-
出版物
GENETICS IN MEDICINE
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-11
DOI
10.1038/s41436-021-01151-8
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A Population-Based Study of Genes Previously Implicated in Breast Cancer
- (2021) Chunling Hu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
- (2021) et al. NEW ENGLAND JOURNAL OF MEDICINE
- Germline mutations of multiple breast cancer-related genes are differentially associated with triple-negative breast cancers and prognostic factors
- (2020) Chihiro Hata et al. JOURNAL OF HUMAN GENETICS
- The contribution of germline predisposition gene mutations to clinical subtypes of invasive breast cancer from a clinical genetic testing cohort
- (2020) Chunling Hu et al. JNCI-Journal of the National Cancer Institute
- Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study
- (2020) Stephanie Archer et al. PLoS One
- Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)
- (2020) Marilyn M. Li et al. GENETICS IN MEDICINE
- TBCRC 048: A phase II study of olaparib monotherapy in metastatic breast cancer patients with germline or somatic mutations in DNA damage response (DDR) pathway genes (Olaparib Expanded).
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women
- (2020) Julie R Palmer et al. JNCI-Journal of the National Cancer Institute
- Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
- (2020) Daniel R. Barnes et al. GENETICS IN MEDICINE
- Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
- (2020) Honglin Song et al. JOURNAL OF MEDICAL GENETICS
- European polygenic risk score for prediction of breast cancer shows similar performance in Asian women
- (2020) Weang-Kee Ho et al. Nature Communications
- Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer Genes
- (2020) Shannon Gallagher et al. JAMA Network Open
- Germline sequencing DNA repair genes in 5,545 men with aggressive and non-aggressive prostate cancer
- (2020) Burcu F Darst et al. JNCI-Journal of the National Cancer Institute
- BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
- (2019) Andrew Lee et al. GENETICS IN MEDICINE
- Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China
- (2019) Mei Deng et al. INTERNATIONAL JOURNAL OF CANCER
- Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers
- (2019) K Nones et al. ANNALS OF ONCOLOGY
- Talazoparib beyond BRCA: A phase II trial of talazoparib monotherapy in BRCA1 and BRCA2 wild-type patients with advanced HER2-negative breast cancer or other solid tumors with a mutation in homologous recombination (HR) pathway genes.
- (2019) Joshua James Gruber et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study
- (2019) Johan Staaf et al. NATURE MEDICINE
- Functional characterization of 84 PALB2 variants of uncertain significance
- (2019) Timothy Wiltshire et al. GENETICS IN MEDICINE
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium
- (2019) Michael Goggins et al. GUT
- A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor
- (2019) Amélie Rodrigue et al. NUCLEIC ACIDS RESEARCH
- Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
- (2019) Rick A. C. M. Boonen et al. Nature Communications
- Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
- (2019) Max M. Wattenberg et al. BRITISH JOURNAL OF CANCER
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
- (2019) Xin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial
- (2019) Joaquin Mateo et al. LANCET ONCOLOGY
- Molecular analysis of PALB2 -associated breast cancers
- (2018) Jue Er Amanda Lee et al. JOURNAL OF PATHOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort
- (2018) Sebastian M Waszak et al. LANCET ONCOLOGY
- OUP accepted manuscript
- (2018) JNCI-Journal of the National Cancer Institute
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
- (2018) Nasim Mavaddat et al. AMERICAN JOURNAL OF HUMAN GENETICS
- A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
- (2018) Marta Castroviejo‐Bermejo et al. EMBO Molecular Medicine
- Germline Mutations in PALB2 , BRCA1 , and RAD51C , Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer
- (2017) Ruta Sahasrabudhe et al. GASTROENTEROLOGY
- A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor
- (2017) Samantha Gadd et al. NATURE GENETICS
- A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
- (2017) Paz Polak et al. NATURE GENETICS
- Compromised BRCA1–PALB2 interaction is associated with breast cancer risk
- (2017) T K Foo et al. ONCOGENE
- Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening†
- (2016) S. Paluch-Shimon et al. ANNALS OF ONCOLOGY
- Incorporating truncating variants in PALB2, CHEK2 and ATM into the BOADICEA breast cancer risk model
- (2016) Andrew J. Lee et al. GENETICS IN MEDICINE
- Genetic modifiers of CHEK2*1100delC-associated breast cancer risk
- (2016) Taru A. Muranen et al. GENETICS IN MEDICINE
- Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis
- (2016) Celine Lefebvre et al. PLOS MEDICINE
- SNPs and breast cancer risk prediction for African American and Hispanic women
- (2015) Richard Allman et al. BREAST CANCER RESEARCH AND TREATMENT
- Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry
- (2015) Tú Nguyen-Dumont et al. BREAST CANCER RESEARCH AND TREATMENT
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
- (2015) Mark E. Robson et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis
- (2015) Cezary Cybulski et al. LANCET ONCOLOGY
- Breast-Cancer Risk in Families with Mutations in PALB2
- (2014) Antonis C. Antoniou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalizing Cancer Treatment in the Age of Global Genomic Analyses: PALB2 Gene Mutations and the Response to DNA Damaging Agents in Pancreatic Cancer
- (2010) M. C. Villarroel et al. MOLECULAR CANCER THERAPEUTICS
- The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype
- (2009) T. Heikkinen et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search